Promoter region polymorphisms in the transforming growth factor beta-1 (TGFβ1) gene and serum TGFβ1 concentration in preeclamptic and control Iranian women

Journal of Reproductive Immunology

Volumn 94, Issue 2, 2012, Pages 216-221

  Feizollahzadeh, Sadegh ^a   Taheripanah, Robabeh ^a   Khani, Masood ^a   Farokhi, Babak ^a   Amani, Dawar ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Iran; Polymorphism; Pre eclampsia; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; TH1 CELL;

ADOLESCENT; ADULT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; IRAN; MUTATION; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PROMOTER REGIONS, GENETIC; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 84861201671     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.02.006     Document Type: Article

References (41)

1. Amani D., Dehaghani A.S., Zolghadri J., Ravangard F., Niikawa N., Yoshiura K., et al. Lack of association between the TGF[beta] 1 gene polymorphisms and recurrent spontaneous abortion. Journal of Reproductive Immunology 2005, 68:91-103.
2. Amani D., Zolghadri J., Dehaghani A.S., Pezeshki A.M., Ghaderi A. The promoter region (-800, -509) polymorphisms of transforming growth factor-[beta] 1 (TGF[beta] 1) gene and recurrent spontaneous abortion. Journal of Reproductive Immunology 2004, 62:159-166.
3. Antonipillai I., Le T.H., Soceneantu L., Horton R. Transforming growth factor-beta is a renin secretagogue at picomolar concentrations. American Journal of Physiology. Renal Physiology 1993, 265:F537.
4. Baran W., Szepietowski J.C., Mazur G., Baran E. TGF[beta] 1 gene polymorphism in psoriasis vulgaris. Cytokine 2007, 38:8-11.
5. Border W.A., Noble N.A. Interactions of transforming growth factor-{beta} and angiotensin II in renal fibrosis. Hypertension 1998, 31:181.
6. Borzychowski A.M., Croy B.A., Chan W.L., Redman C.W.G., Sargent I.L. Changes in systemic type 1 and type 2 immunity in normal pregnancy and preeclampsia may be mediated by natural killer cells. European Journal of Immunology 2005, 35:3054-3063.
7. Bowen J.M., Chamley L., Mitchell M.D., Keelan J.A. Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 2002, 23:239-256.
8. Cambien F., Ricard S., Troesch A., Mallet C., Generenaz L., Evans A., et al. Polymorphisms of the TGF 1 gene in relation to myocardial infarction and blood pressure - the ectim study. Hypertension 1996, 28:881-887.
9. Clark D.A., Coker R. Molecules in focus transforming growth factor-beta (TGF[beta]). The International Journal of Biochemistry & Cell Biology 1998, 30:293-298.
10. Cotton S.A., Gbadegesin R.A., Williams S., Brenchley P.E.C., Webb N.J.A. Role of TGFβ1 in renal parenchymal scarring following childhood urinary tract infection. Kidney International 2002, 61:61-67.
11. Daher S., Sass N., Oliveira L.G., Mattar R. Cytokine genotyping in preeclampsia. American Journal of Reproductive Immunology 2006, 55:130-135.
12. Docherty N.G., Pérez-Barriocanal F., Balboa N.E., López-Novoa J.M. Transforming growth factor-1 (TGFβ1): a potential recovery signal in the post-ischemic kidney. Renal Failure 2002, 24:391-406.
13. Enquobahrie D.A., Williams M.A., Qiu C., Woelk G.B., Mahomed K. Maternal plasma transforming growth factor-β1 concentrations in preeclamptic and normotensive pregnant zimbabwean women. The Journal of Maternal-Fetal & Neonatal Medicine 2005, 17:343-348.
14. Grainger D.J., Heathcote K., Chiano M., Snieder H., Kemp P.R., Metcalfe J.C., et al. Genetic control of the circulating concentration of transforming growth factor type 1. Human Molecular Genetics 1999, 8:93.
15. Hennessy A.M., Orange S., Willis N., Painter D.M., Child A., Horvath J.S. Transforming growth factor-β1 does not relate to hypertension in preeclampsia. Clinical and Experimental Pharmacology and Physiology 2002, 29:968-971.
16. Khalil N. TGF[beta]: from latent to active. Microbes and Infection 1999, 1:1255-1263.
17. Khan K.S., Wojdyla D., Say L., Gülmezoglu A.M., Van Look P.F. Who analysis of causes of maternal death: a systematic review. The Lancet 2006, 367:1066-1074.
18. Lisi V., Paternoster D.M., Stecca A., Micciché F., Fantinato S., Leon A., et al. Investigation of endothelin-1 type a receptor gene polymorphism (-231G>A) in preeclampsia susceptibility. The Journal of Maternal-Fetal & Neonatal Medicine 2007, 20:145-149.
19. Luedecking E.K., DeKosky S.T., Mehdi H., Ganguli M., Kamboh M.I. Analysis of genetic polymorphisms in the transforming growth factor-β 1 gene and the risk of alzheimer's disease. Human Genetics 2000, 106:565-569.
20. Matthiesena L., Berga G., Ernerudhb J., Ekerfeltb C., Jonssonb Y., Sharmac S. Immunology of preeclampsia. Chemical Immunology and Allergy 2005, 89:49-61.
21. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 1988, 16:1215.
22. Miskovi B., Serti J., Stavljeni -Rukavina A., Stipoljev F. Association of angiotensin-converting enzyme insertion-deletion polymorphism with preeclampsia. Collegium Antropologicum 2008, 32:339.
23. Molvarec A., Jermendy A., Nagy B., Kovacs M., Varkonyi T., Hupuczi p., et al. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction. Clinica Chimica Acta 2008, 392:52-57.
24. Moustakas A., Pardali K., Gaal A., Heldin C.H. Mechanisms of TGF[beta] signaling in regulation of cell growth and differentiation. Immunology Letters 2002, 82:85-91.
25. Muy-Rivera M., Sanchez S.E., Vadachkoria S., Qiu C., Bazul V., Williams M.A. Transforming growth factor-[beta] 1 (TGF[beta] 1) in plasma is associated with preeclampsia risk in peruvian women with systemic inflammation. American Journal of Hypertension 2004, 17:334-338.
26. Ohtsuka T., Yamakage A., Yamazaki S. The polymorphism of transforming growth factor 1 gene in japanese patients with systemic sclerosis. British Journal of Dermatology 2002, 147:458-463.
27. Pulleyn L.J., Newton R., Adcock I.M., Barnes P.J. TGFβ1 allele association with asthma severity. Human Genetics 2001, 109:623-627.
28. Raghupathy R. Pregnancy: Success and Failure Within the Th1/Th2/Th3 Paradigm 2001, Elsevier, pp. 219-227.
29. Saito S. Cytokine network at the feto-maternal interface. Journal of Reproductive Immunology 2000, 47:87-103.
30. Saito S., Nakashima A., Shima T., Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. American Journal of Reproductive Immunology 2010, 63(6):601-610.
31. Schulte C.M.S., Goebell H., Rher H.D., Schulte K.M. C-509T polymorphism in the tgfb1 gene promoter: impact on crohn's disease susceptibility and clinical course?. Immunogenetics 2001, 53:178-182.
32. Serrano N.C., Díaz L.A., Páez M.C., Mesa C.M., Cifuentes R., Monterrosa A., et al. Angiotensin-converting enzyme i/d polymorphism and preeclampsia risk: evidence of small-study bias. PLoS Medicine 2006, 3:e520.
33. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. The Lancet 2005, 365:785-799.
34. Stonek F., Hafner E., Metzenbauer M., Katharina S., Stümpflen I., Schneeberger C., et al. Absence of an association of tumor necrosis factor (TNF)-alpha g308a, interleukin-6 (IL-6) g174c and interleukin-10 (ILl-10) g1082a polymorphism in women with preeclampsia. Journal of Reproductive Immunology 2008, 77:85-90.
35. Sugiura Y., Niimi T., Sato S., Yoshinouchi T., Banno S., Naniwa T., et al. Transforming growth factor 1 gene polymorphism in rheumatoid arthritis. Annals of the Rheumatic Diseases 2002, 61:826.
36. Syrris P., Carter N.D., Metcalfe J.C., Kemp P.R., Grainger D.J., Kaski J.C., et al. Transforming growth factor-b1 gene polymorphisms and coronary artery disease. Clinical Science 1998, 95:659-667.
37. Szarka A., Rigó J.J.r., Lázár L., Beko G., Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunology 2010, 11:59.
38. Venkatesha S., Toporsian M., Lam C., Hanai J., Mammoto T., Kim Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature Medicine 2006, 12:642-649.
39. Vural P., Degirmencioglu S., Saral N.Y., Demirkan A., Akgul C., Yildirim G., et al. Tumor necrosis factor, interleukin-6 and interleukin-10 polymorphisms in preeclampsia. Journal of Obstetrics and Gynaecology Research 2010, 36:64-71.
40. Wang B., Morinobu A., Kanagawa S., Koshiba M., Hashimoto H., Kumagai S. Transforming growth factor beta 1 gene polymorphism in japanese patients with systemic lupus erythematosus. The Kobe Journal of Medical Sciences 2007, 53:15-23.
41. Wilczyski J.R., Tchrzewski H., Banasik M., Gowacka E., Wieczorek A., Lewkowicz P., et al. Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 2003, 109:8-15.